| Company Name: |
Patheon Inc. |
| Business: |
Contract pharmaceutical dosage form development and manufacturing services |
| Established: |
1974 |
| Corporate Office: |
US Headquarters
Patheon Inc.
4721 Emperor Boulevard, Suite 200
Durham, N.C. 27703
Phone:919-226-3200
|
| Annual Revenues: |
US$ 671.2M (2010 Fiscal Year) |
| Fiscal Year End: |
October 31 |
| Trading Symbol: |
PTI (traded on TSX – Toronto Stock Exchange) |
| Total Employees: |
Approximately 4,000 |
| Number of Facilities: |
9 |
| Customers Served: |
Approximately 300 |
| Development Centers: |
8 |
| Development Scientists: |
Approximately 600 scientists with nearly 100 Ph.Ds |
| Projects in Development: |
300 |
Capabilities at a Glance
Patheon offers a full range of pharmaceutical development and manufacturing across its international network of facilities.
Click here to view a matrix of Patheon’s development and manufacturing capabilities.